Brown-Forman Looks 26% Undervalued, but Fear Over the Last Quarter May Be Overdone

Brown-Forman's selloff looks more emotional than fundamental

The market is punishing Brown-Forman for a bad quarter, not yet for a broken business.

The quarter was bad, but it may not be the whole story

After a report in which EPS missed at $0.12 versus a $0.33 expectation and shares lost about 5% since the beginning of the year, investors are acting like one print rewrites the entire business. That is a understandable reaction, but it may be too narrow. The Street's consensus price target is $35.30, which suggests the market still sees value in the story even while sentiment is weak.

Brown-Forman has not helped confidence. Over the last four quarters, it has surpassed consensus EPS estimates just once, and the stock has underperformed the market. That string of mixed surprises has trained investors to expect another disappointment. The question now is whether one ugly quarter has become a permanent label.

Full-year results still point to a workable base

The full-year picture was softer than ideal, but not broken. In fiscal 2026, management said it finished ahead of our expectations. Full-year reported net sales decreased 1% to $3.9 billion, while reported operating income decreased 10% to $1.0 billion (-2% on an organic basis). That reads more like a difficult stretch than a collapse in earning power.

The quarter hurt profits more than sales

What matters now is not the headline EPS miss alone, but the rest of the quarter.

Sales held up while margins compressed

The market's first reaction was understandable: EPS of $0.12 versus a $0.33 expectation is a sharp miss, and the -63.82% earnings surprise gave traders a simple reason to sell. If earnings can fall from $0.31 a year ago to $0.12, investors naturally worry about demand, pricing, and the durability of the business.

But the quarter was more mixed than that headline implies. Reported net sales increased 2% to $912 million. The bigger problem was profitability: reported operating income decreased 53% to $96 million. In other words, the market is reacting to a profit squeeze, not a top-line failure.

Why the valuation debate still matters

That distinction matters because valuation starts from operating power. Brown-Forman still generated $1.0 billion of operating income on $3.9 billion of net sales, with a 25.5% operating margin. Even after the selloff, that earning base still exists. If results simply stabilize rather than keep degrading, the current reaction may look harsher than the underlying business change.

The next few quarters need to prove stability

Estimate stability matters more than a new story

The rebound case now rests on estimates finding a floor. After the $0.12 EPS print, the key issue is whether expectations stop sliding. With Brown-Forman having surpassed consensus EPS estimates just once over the last four quarters, investors have reason to stay skeptical. Another miss would likely confirm that the market is right to question earnings quality.

Analyst opinions show the split view

That tension is clear in analyst behavior. Targets range from $20 to $69, with a $35.30 mean price target and a Neutral consensus rating. The spread shows that upside still exists in the story, but confidence has not been restored.

What would improve the setup

Investors should watch for a few concrete signals over the next few reports: - whether sales remain steadier than earnings suggest - whether profit pressure eases from the recent quarter - whether full-year trends start to look more like stabilization than deterioration

What would break the setup

Management already warned of continued market volatility and a challenging cost cycle. If costs rise again or execution slips, the market is likely to treat this as a durability problem rather than a temporary reset.